Safety and efficacy of four drug regimens versus standard-of-care for the treatment of symptomatic outpatients with COVID-19: A randomised, open-label, multi-arm, phase 2 clinical trial.
Exploratory Study of Four Repurposed Anti-Infective Drug Regimens
Search
Recent News
- World Sleep Congress 2023: 20 – 25 October Rio de Janeiro, Brazil
- REDCap Africa Symposium 2023: 19 – 20 October Cape Town
- 2023 SAHCS Conference: 8 – 10 November Cape Town
- Practice of the Future Conference: 16 September 2023, Boksburg, Johannesbug
- IAS Conference on HIV Science: 23 – 26 July 2023 Brisbane, Australia